OSE IMMUNO (OSE.PA)

FR0012127173 - Common Stock

7.06  +0.05 (+0.71%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
26.306M
152.17%		18.302M
-30.43%		2.227M
-87.83%		72.791M
3,168.57%		57.386M
-21.16%		82.483M
43.73%
EBITDA
YoY % growth
-13.679M
25.08%		-14.752M
-7.84%		-19.927M
-35.08%		57.787M
389.99%		41.271M
-28.58%		43.026M
4.25%
EBIT
YoY % growth
-16.336M
13.97%		-18.289M
-11.96%		-23.347M
-27.66%		44.683M
291.39%		17.988M
-59.74%		-18.685M
-203.87%
Operating Margin
-62.10%-99.93%-1,048.36%61.39%31.35%-22.65%
EPS
YoY % growth
N/A
-2.27%		N/A
-75.32%		N/A
-9.25%		1.84
250.83%		1.50
-18.54%		1.27
-15.46%

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth		 82.573M
5,980.49%		%
Q4 2023
Q2Q % growth		 869K
-61.46%		%
Q2 2023
Q2Q % growth		 1.358M
-91.54%		%
Q4 2022
Q2Q % growth		 2.255M
-86.99%		%
Q2 2022
Q2Q % growth		 16.047M
78.80%		%
Q4 2021
Q2Q % growth		 17.331M
278.16%		%
Q2 2021
Q2Q % growth		 8.975M
53.45%		%
Q4 2020
Q2Q % growth		 4.583M
-54.05%		%
Q2 2020
Q2Q % growth		 5.849M
-63.40%		%
Q4 2019
Q2Q % growth		 9.973M
159.17%		%
Q2 2019
Q2Q % growth		 15.979M
-22.46%		%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% -20%
RevenueN/A N/A 0% -7.39%